1.
Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for targeted therapies
by Forest, Fabien, MD
Human pathology, 2015, Vol.49, p.99-106
2.
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
by Yuen, Kobe C
Nature medicine, 2020, Vol.26 (5), p.693-698
3.
Salivary gland epithelial neoplasms in pediatric population: a single-institute experience with a focus on the histologic spectrum and clinical outcome
by Xu, Bin
Human pathology, 2017, Vol.67, p.37-44
4.
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning
by Coudray, Nicolas
Nature medicine, 2018, Vol.24 (10), p.1559-1567
5.
Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer
by Choi, Jung Eun
Annals of surgical oncology, 2014, Vol.22 (1), p.82-89
6.
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB n...
by Bradley, Jeffrey D, Prof
The lancet oncology, 2015, Vol.16 (2), p.187-199
7.
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
by Rudin, Charles M, Prof
The lancet oncology, 2016, Vol.18 (1), p.42-51
8.
Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study
by Ciatto, Stefano, PhD
The lancet oncology, 2013, Vol.14 (7), p.583-589
9.
Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective s...
by Bernardi, Daniela, MD
The lancet oncology, 2016, Vol.17 (8), p.1105-1113
10.
Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma
by Patel, Kalyani R., MD
Human pathology, 2013, Vol.44 (11), p.2501-2508
11.
Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for...
by Polgár, Csaba, Prof
The lancet oncology, 2017, Vol.18 (2), p.259-268
12.
CH5424802 (RO5424802) for patients with ALK -rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study
by Seto, Takashi, MD
The lancet oncology, 2013, Vol.14 (7), p.590-598
13.
Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma
by Bishop, Justin A., MD
Human pathology, 2013, Vol.44 (10), p.1982-1988
14.
Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients
by Azab, Basem
Annals of surgical oncology, 2011, Vol.19 (1), p.217-224
15.
Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery
by Lee, Jang Hyuck
Annals of surgical oncology, 2019, Vol.26 (11), p.3756-3764
16.
Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study
by Brunnström, Hans
American journal of clinical pathology, 2013, Vol.140 (1), p.37-46
17.
Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institution...
by Nakhlis, Faina
Annals of surgical oncology, 2015, Vol.23 (3), p.722-728
18.
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH...
by Vilgrain, Valérie
The lancet oncology, 2017, Vol.18 (12), p.1624-1636
19.
Prognostic alternative mRNA splicing signature in non-small cell lung cancer
by Li, Yuan
Cancer letters, 2017, Vol.393, p.40-51
20.
Differential expression of inflammasomes in lung cancer cell lines and tissues
by Kong, Hui
Tumor biology, 2015, Vol.36 (10), p.7501-7513
